Information PortalData PortalKnowledge Portal

Data Matrix

Tools & Workflows

Documentation

Mantle cell lymphoma (Disease Or Phenotype)

Omim:607585

Nci:C4337

Msh:D020522

Mondo:MONDO:18876

Medcin:MEDCIN:312883

Mdr:MDR:10026806

Id:b80c1056-37a7-55e6-a7d2-e3ca442bc17c

Icpc2icd10eng:MTHU023070

Icd10cm:C83.1

Efo:EFO:1001469

Doid:DOID:50746

Chv:CHV:30015

Results found

Linked to

	Label	Description
	fludarabine indication Mantle cell lymphoma Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Lenalidomide indication Mantle cell lymphoma Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	1,18-Dihydroxy-12-[2-(4-hydroxy-3-methoxy-cyclohexyl)-1-methyl-ethyl]-19,30,33-trimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-aza-tricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentaone;Rapamycin indication Mantle cell lymphoma Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	temsirolimus indication Mantle cell lymphoma Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Fludarabine phosphate indication Mantle cell lymphoma Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Zanubrutinib indication Mantle cell lymphoma Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	IBRUTINIB::US9108973, Ref 1::US9181263, 1::US9278100, 1 indication Mantle cell lymphoma Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	acalabrutinib indication Mantle cell lymphoma Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Dipeptidyl boronic acid derivative indication Mantle cell lymphoma Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

fludarabine indication Mantle cell lymphoma

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Lenalidomide indication Mantle cell lymphoma

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

1,18-Dihydroxy-12-[2-(4-hydroxy-3-methoxy-cyclohexyl)-1-methyl-ethyl]-19,30,33-trimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-aza-tricyclo[30.3.1.0*4,9*]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentaone;Rapamycin indication Mantle cell lymphoma

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

temsirolimus indication Mantle cell lymphoma

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Fludarabine phosphate indication Mantle cell lymphoma

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Zanubrutinib indication Mantle cell lymphoma

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

IBRUTINIB::US9108973, Ref 1::US9181263, 1::US9278100, 1 indication Mantle cell lymphoma

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

acalabrutinib indication Mantle cell lymphoma

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Dipeptidyl boronic acid derivative indication Mantle cell lymphoma

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.